ストックスクリーナーアプリを入手
77.82
3.09%
-2.48
プレマーケット:
77.82
前日終値:
$80.30
開ける：
$80.02
24時間の取引高:
2.08M
Relative Volume:
1.27
時価総額：
$37.93B
収益：
$10.40B
当期純損益:
$980.00M
株価収益率:
39.40
EPS:
1.9749
ネットキャッシュフロー:
$1.61B
1週間 パフォーマンス:
-2.65%
1か月 パフォーマンス:
+5.66%
6か月 パフォーマンス:
+2.72%
1年 パフォーマンス:
-14.84%
1日の値動き範囲:
$77.36
$80.28
1週間の範囲:
$77.36
$82.36
52週間の値動き範囲:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
77.82 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
ISRG
Intuitive Surgical Inc
|
451.29 | 160.28B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.69 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
47.51 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
221.22 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-26 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 開始されました | William Blair | Mkt Perform |
| 2026-01-20 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-09 | ダウングレード | Stifel | Buy → Hold |
| 2025-12-11 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-08-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-05-20 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 繰り返されました | BTIG Research | Buy |
| 2025-03-28 | 繰り返されました | Needham | Buy |
| 2025-03-25 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-01-24 | 繰り返されました | Needham | Buy |
| 2025-01-10 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 繰り返されました | Needham | Buy |
| 2024-11-12 | 繰り返されました | Needham | Buy |
| 2024-10-10 | アップグレード | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 開始されました | Goldman | Buy |
| 2024-03-14 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 開始されました | Bernstein | Outperform |
| 2023-12-18 | ダウングレード | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-10 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | アップグレード | Societe Generale | Sell → Hold |
| 2022-12-22 | 開始されました | Mizuho | Buy |
| 2022-11-17 | ダウングレード | Societe Generale | Hold → Sell |
| 2022-08-11 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-05-13 | 再開されました | Credit Suisse | Outperform |
| 2022-05-12 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-11 | 開始されました | BofA Securities | Buy |
| 2022-01-18 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 開始されました | Oppenheimer | Perform |
| 2021-07-14 | 開始されました | Deutsche Bank | Buy |
| 2021-05-06 | アップグレード | Citigroup | Sell → Neutral |
| 2021-03-22 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-11-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-07-06 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-07-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-04-08 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Argus | Hold → Buy |
| 2020-03-24 | アップグレード | Societe Generale | Sell → Hold |
| 2020-03-13 | アップグレード | UBS | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-26 | アップグレード | Berenberg | Hold → Buy |
| 2020-01-08 | 開始されました | Argus | Hold |
| 2019-10-29 | 開始されました | Stephens | Equal-Weight |
| 2019-08-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-06-24 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-06-14 | 開始されました | BTIG Research | Neutral |
| 2019-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Alcon Inc (ALC) 最新ニュース
Alcon inks incentives deal for $186 million Fort Worth expansion - The Business Journals
Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100 - GuruFocus
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential - Yahoo Finance
Alcon Inc. stock (CH0432492467): Is its eye care dominance strong enough to unlock new upside? - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough to unlock steady growth? - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough for sustained U.S. investor - AD HOC NEWS
National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others - The Manila Times
National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others - GlobeNewswire Inc.
On the Record: Alcon invests $60M in Cabell County facility - MSN
Alcon Inc. (ALC) Stock Analysis: A 16.43% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough for steady investor gains? - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Is vision care dominance strong enough to unlock steady growth for - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough to unlock steady upside? - AD HOC NEWS
Systane Augentropfen: Eye Relief Demand Surges Amid Screen Time Boom - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough to unlock new upside? - AD HOC NEWS
Systane Augentropfen: Dry Eye Relief Gains Traction Amid Screen Time Surge - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough for steady U.S. investor ret - AD HOC NEWS
Alcon Inc stock (CH0432492467): Why Google Discover changes matter more now - AD HOC NEWS
Sight Sciences wins $34M patent ruling against Alcon - MSN
Systane Augentropfen: Eye Health Demand Surges Amid Screen Time Boom - AD HOC NEWS
Optician OnlineWCO & Alcon release interactive DED toolOptician Online - Trucknet UK
Bernstein SocGen reiterates Alcon stock rating on dry eye outlook - Investing.com UK
Bernstein SocGen reiterates Alcon stock rating on dry eye outlook By Investing.com - Investing.com Australia
Alcon Inc. stock (CH0432492467): Why does its eye care dominance matter more for U.S. investors now? - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is vision care demand strong enough to sustain long-term growth? - AD HOC NEWS
Are Medical Stocks Lagging Alcon (ALC) This Year? - Yahoo Finance
Alcon Announces U.S. Launch of Clareon TruPlus IOLs - VisionMonday.com
Systane Augentropfen: Eye Health Boom Puts Alcon's Dry Eye Leader in Focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is vision care dominance strong enough to unlock new upside? - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is vision care's steady growth strong enough to unlock new upside? - AD HOC NEWS
Analysis Recap: Will Alcon Inc benefit from rate cutsEarnings Miss & Weekly High Momentum Picks - baoquankhu1.vn
Alcon launches Clareon TruPlus monofocal and toric IOL - Eyes On Eyecare
Alcon Inc stock: What you need to know before investing now - AD HOC NEWS
Assessing Alcon (SWX:ALC) Valuation After Clareon TruPlus Lens Launch At ASCRS Meeting - Yahoo Finance
Is It Time To Reconsider Alcon (SWX:ALC) After Its 15.5% One Year Share Price Decline - Yahoo Finance
This mining merger gives Alcon holders 61% of the combined company - Stock Titan
Bridges Investment Fund's Alcon Inc(ALC) Holding History - GuruFocus
Alcon Inc (ALC) Trading 3.96% Higher on Apr 8 - GuruFocus
AB SUSTAINABLE INTERNATIONAL THEMATIC FUND INC's Alcon Inc(XSWX:ALC) Holding History - GuruFocus
Alcon Shares Rise After Introducing Clareon TruPlus at ASCRS - Bitget
Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS - Yahoo Finance
Alcon Inc. stock: Why eye health leader stands out for investors now - AD HOC NEWS
U.S. Federal Trade Commission – Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns - marketscreener.com
Former Alcon executive named as chief operating officer at biotech company Nanoscope - Fort Worth Report
Alcon Inc stock: What you should know about its eye care leadership now - AD HOC NEWS
Blue Jays eye-drop deal spotlights dry eye for 8.5 million Canadians - Stock Titan
Alcon Inc stock: What investors should know about its eye care leadership now - AD HOC NEWS
Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S. - GuruFocus
Alcon Rolls Out Clareon TruPlus Intraocular Lens in U.S. - Medical Product Outsourcing
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo Finance
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026 - Business Wire
Alcon Inc (ALC) 財務データ
収益
当期純利益
現金流量
EPS
1.55%
1.85%
大文字化:
|
ボリューム (24 時間):